Starcević Boris, Sikić Jozica, Sicaja Mario, Udovicić Mario, Stipcević Mira, Bergovec Mijo
Department of Cardiovascular Diseases, University Department of Medicine, Dubrava University Hospital, Zagreb, Croatia.
Acta Med Croatica. 2009 Feb;63(1):59-62.
Cardiovascular diseases are the leading cause of mortality in Croatia. In concordance with this epidemiologic situation, a new organization of emergency medicine and a network of invasive cardiac laboratories have been introduced throughout Croatia. Main goal of this structuring is to improve the care of patients with acute coronary syndrome (ACS). The aim of this paper is to open discussion on the optimal way of treatment in patients with ACS in our country today, in the era of interventional cardiology of the 21st century. The pathophysiology of ACS encompasses a complex atheroinflammatory and atherothrombotic process with dynamic and progressive mechanical obstruction of coronary arteries and subsequently oxygen supply-demand mismatch. Conversely, the best way to treat such patients is reperfusion therapy, a goal nowadays achieved by either antithrombotic medical therapy or percutaneous coronary intervention (PCI). The weight of evidence does support the use of primary PCI as a standard and supreme reperfusion therapy, especially in myocardial infarction with ST elevation. The logistic complexities such as triage, transportation, the development of capable interventional center working 24-hours, even in developed countries, may be a major problem to use such a practice in the whole community. In ACS with non ST elevation, problems are even broader and include the importance of using optimal revascularization procedure (even cardiac surgery), timing and concomitant medical therapy, with certain stratification of every individual. Finally, especially for our country, medical and economic resources should be used optimally in order to achieve an optimal system to treat patients with ACS.
心血管疾病是克罗地亚的主要死因。鉴于这种流行病学情况,克罗地亚各地引入了新的急诊医学组织和侵入性心脏实验室网络。这种结构调整的主要目标是改善急性冠状动脉综合征(ACS)患者的护理。本文旨在开启关于在当今21世纪介入心脏病学时代我国ACS患者最佳治疗方式的讨论。ACS的病理生理学包括一个复杂的动脉粥样硬化炎症和动脉粥样硬化血栓形成过程,伴有冠状动脉的动态和进行性机械性阻塞,进而导致氧供需不匹配。相反,治疗此类患者的最佳方法是再灌注治疗,如今这一目标可通过抗血栓药物治疗或经皮冠状动脉介入治疗(PCI)实现。大量证据确实支持将直接PCI作为标准且最佳的再灌注治疗方法,尤其是在ST段抬高型心肌梗死中。即使在发达国家,诸如分诊、转运、建立24小时运作的有能力的介入中心等后勤复杂性问题,可能是在整个社区采用这种治疗方法的一个主要问题。在非ST段抬高型ACS中,问题甚至更为广泛,包括使用最佳血运重建程序(甚至心脏手术)的重要性、时机和伴随的药物治疗,以及对每个个体进行特定分层。最后,特别是对于我国而言,应优化医疗和经济资源的使用,以实现治疗ACS患者的最佳系统。